2022 World Conference on Lung Cancer (ePosters)-EP08.03-008. Whether Immunotherapy Should Be Maintained or Not After Acquired Resistance in Advanced NSCLC

EP08.03-008. Whether Immunotherapy Should Be Maintained or Not After Acquired Resistance in Advanced NSCLC

Pdf Summary

Summary Not Available

Asset Subtitle

Shun Lu

Meta Tag

Speaker Shun Lu

Topic Metastatic Non-small Cell Lung Cancer Oligometastatic Disease